Mareque M, Climente M, Martinez-Moragon E, Padilla A, et al. COST-EFFECTIVENESS OF BENRALIZUMAB VERSUS MEPOLIZUMAB AND DUPILUMAB IN PATIENTS WITH SEVERE UNCONTROLLED EOSINOPHILIC ASTHMA IN SPAIN. J Asthma 2022 Nov 2:1-13. doi: 10.1080/02770903.2022.2139718.
PMID: 36322679